Impax announced that the Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Emverm (mebendazole) chewable tablets. Impax announced that the Food and ...

Janssen Pharmaceuticals, a unit of Johnson & Johnson ($JNJ), has submitted a new drug application to the FDA for a 500-milligram chewable tablet targeting intestinal ...